Frontiers | Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor
GIST Mutations - Types of GIST Cancer Gene Mutations & Testing | The Life Raft Group
Discovery of Conformational Control Inhibitors Switching off the Activated c -KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants | Journal of Medicinal Chemistry
Traces of cKIT model and imatinib binding. A, model of the inactive... | Download Scientific Diagram
Secondary KIT mutations: the GIST of drug resistance and sensitivity | British Journal of Cancer
A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors - Kim - 2022 - Molecular Oncology - Wiley Online Library
NOVELTY NOBILITY Inc.
Cancers | Free Full-Text | Resistance to Molecularly Targeted Therapies in Melanoma
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients | PNAS
c-KIT and PDGFRA mutation detection for GIST – آزمایشگاه پرتولب
Cancer drug gets a makeover | News | Chemistry World
![PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/52568705464442ace5fec86bca4a1528e3281c4b/70-FigureV-1.png "PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar")
PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar
Visualisation of the action of imatinib at the KIT receptor | Download Scientific Diagram
![PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a2caa75b0240b9cad38286da89c68152befd2d7/11-Figure9-1.png "PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar")
PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review | Biomolecules and Biomedicine
Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor | BMC Medicine | Full Text
IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia
EPOS™
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor - ScienceDirect
Chemical structure of imatinib and its binding modes to c-Kit and Abl.... | Download Scientific Diagram
Imatinib Mesylate — A New Oral Targeted Therapy | NEJM
c-キッ阻害 | c-Kit Inhibition
Imatinib‑induced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress
Journal of Biomedical and Pharmaceutical Research
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer
